5-Fluorouracil Treatment Represses Pseudouridine-Containing Small RNA Export into Extracellular Vesicles

Sherman Qu,Hannah Nelson,Xiao Liu,Elizabeth Semler,Danielle L. Michell,Clark Massick,Jeffrey L. Franklin,John Karijolich,Alissa M. Weaver,Robert J. Coffey,Qi Liu,Kasey C. Vickers,James G. Patton
DOI: https://doi.org/10.1101/2024.01.15.575751
2024-01-17
Abstract:5-fluorouracil (5-FU) has been used for chemotherapy for colorectal and other cancers for over 50 years. The prevailing view of its mechanism of action is inhibition of thymidine synthase leading to defects in DNA replication and repair. However, 5-FU is also incorporated into RNA causing toxicity due to defects in RNA metabolism, inhibition of pseudouridine modification, and altered ribosome function. Here, we examine the impact of 5-FU on the expression and export of small RNAs (sRNAs) into small extracellular vesicles (sEVs). Moreover, we assess the role of 5-FU in regulation of post-transcriptional sRNA modifications (PTxM) using mass spectrometry approaches. EVs are secreted by all cells and contain a variety of proteins and RNAs that can function in cell-cell communication. PTxMs on cellular and extracellular sRNAs provide yet another layer of gene regulation. We found that treatment of the colorectal cancer (CRC) cell line DLD-1 with 5-FU led to surprising differential export of miRNA snRNA, and snoRNA transcripts. Strikingly, 5-FU treatment significantly decreased the levels of pseudouridine on both cellular and secreted EV sRNAs. In contrast, 5-FU exposure led to increased levels of cellular sRNAs containing a variety of methyl-modified bases. Our results suggest that 5-FU exposure leads to altered expression, base modifications, and mislocalization of EV base-modified sRNAs.
Molecular Biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the influence of 5 - fluorouracil (5 - FU) on the expression of small RNAs (sRNAs) and their export into small extracellular vesicles (sEVs), especially the changes in post - transcriptional RNA modifications (PTxM). 5 - FU is a commonly used chemotherapeutic drug, mainly used for the treatment of colorectal cancer and other cancers. Its traditional mechanism of action is considered to be through inhibiting thymidylate synthase to impede DNA replication and repair. However, recent studies have shown that 5 - FU can also affect RNA metabolism, leading to RNA defects, inhibiting pseudouridine modification, and changing ribosome function. Therefore, this paper further investigates how 5 - FU affects the expression, base modification, and selective export of small RNAs in intracellular and extracellular vesicles, especially focusing on the role of pseudouridine modification in this process. Specifically, the authors studied the effects of 5 - FU treatment on the following aspects: 1. **Expression of small RNAs**: Analyze the expression changes of small RNAs in cells and secreted into sEVs before and after 5 - FU treatment by RNA sequencing technology. 2. **Post - transcriptional modification of small RNAs**: Quantitatively detect the level changes of various post - transcriptional modifications (such as pseudouridine, methylation, etc.) in cells and sEVs before and after 5 - FU treatment using liquid chromatography - tandem mass spectrometry (LC - MS/MS) technology. 3. **Export of small RNAs**: Explore whether 5 - FU treatment will affect the transfer of specific types of small RNAs (such as miRNA, snRNA, snoRNA, etc.) from cells to sEVs. The research results show that 5 - FU treatment significantly reduces the levels of pseudouridine in cells and sEVs, resulting in a decrease in the export of miRNA and snRNA, while an increase in the export of snoRNA. In addition, 5 - FU treatment also leads to the up - regulation or down - regulation of the expression of some small RNAs in cells, and these changes may be related to post - transcriptional modification of RNA. These findings provide a new perspective for understanding the pleiotropic effects of 5 - FU, especially its influence at the RNA level.